Homepage 080118

Bo Norberg

Bo Norberg is the editor of The Rondel. His main research interests at present are B12-associated medical problems and premature heart infarcts within some families of Northern Sweden. His university affiliation is The Department of Internal Medicine, University Hospital of Northern Sweden, SE-901 85 Umeå, Sweden.

Bo Norberg is available as lecturer, translator, author, and adviser, provided that problems and terms are suitable. His present views on health care, work organization, medical education and training, human psychology, ethics and Holy Bible are also evident from his essays in The Rondel, columns "Health" and "Culture".

Key words:

B12
Medical education
Medical training
Health care
Work organization
Human psychology
Holy Bible

Possible conflicts of interests

Adviser (advice, lectures, clinical expert reports) on B12-associated problems 1990-2008 to:

Abbot, Sweden
Abigo, Sweden
Astra Hässle, Sweden (now Astra Zeneca, UK)
Bristol-Myers-Squibb, Sweden
Buckingham, Doolittle & Burroughs (Ohio)
Conpharm, Sweden (now Meda, Sweden)
Dumex, Denmark (later Alpharma, Norway, now Actavis, Iceland)
Goldshield, UK
Meda, Sweden
Pfizer, Sweden
Pharmacia, Sweden (now Pfizer, Sweden)
Woerwag, Germany

See also Curriculum vitae.